Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods - Scorecard - MDSpire
Advertisement
Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods
Clinical Scorecard: Evaluating the Applicability of SARS-CoV-2 Seroprevalence Findings to the Pediatric Population in Montréal: A Comparison of Two Weighting Approaches
At a Glance
Category
Detail
Condition
SARS-CoV-2 infection seroprevalence
Key Mechanisms
Assessment of immunoglobulin G antibody response to SARS-CoV-2 infection using serological assays
Target Population
Children aged 2-17 years in Montréal, Canada
Care Setting
Community-based pediatric population surveillance
Key Highlights
Seroprevalence studies often use nonrandom, nonrepresentative samples limiting generalizability.
Two weighting methods, marginal standardization and raking, were compared to improve representativity.
Raking was preferred for its ability to weight simultaneously for multiple underrepresented population characteristics.
Guideline-Based Recommendations
Diagnosis
Use serological assays with high sensitivity and specificity (e.g., ELISA targeting receptor-binding domain of spike protein) to detect SARS-CoV-2 antibodies in pediatric populations.
Management
Consider seroprevalence data to inform public health strategies targeting pediatric populations.
Monitoring & Follow-up
Apply appropriate weighting methods to seroprevalence data to improve representativeness and generalizability to the target population.
Risks
Nonrandom sampling can lead to under- or overestimation of infection prevalence and misidentification of high-risk groups.
Patient & Prescribing Data
Pediatric patients aged 2-17 years in Montréal
Not applicable; study focuses on seroprevalence estimation rather than treatment.
Clinical Best Practices
Recruit participants from diverse neighborhoods reflecting socioeconomic variability to improve sample representativeness.
Use multiple imputation techniques to address missing data in seroprevalence studies.
Prefer raking weighting methods when adjusting seroprevalence estimates to account for multiple demographic characteristics simultaneously.
